+ All Categories
Home > Documents > Abstract Abstract Introduction Introduction Results Chee Yang, Daniel H. Rose and Dr. Thao Yang ...

Abstract Abstract Introduction Introduction Results Chee Yang, Daniel H. Rose and Dr. Thao Yang ...

Date post: 13-Jan-2016
Category:
Upload: quentin-laurence-ferguson
View: 213 times
Download: 1 times
Share this document with a friend
Popular Tags:
1
Abstract Abstract Introduction Introduction Results Results Chee Yang, Daniel H. Rose and Dr. Thao Yang Chee Yang, Daniel H. Rose and Dr. Thao Yang Chemistry Chemistry University of University of Wisconsin-Eau Claire Wisconsin-Eau Claire The amino acid sequence Arg-Gly-Asp or RGD is present on several extracellular matrix proteins and known to be a requirement for their binding to integrins, which are a class of cell receptor proteins on cell surface. Some of the well- studied extracellular matrix proteins included fibrinogen, fibronectin, vitronectin, collagen, and laminin, which contain the RGD sequence. Subsequent studies in this project will focus on the conformational structures of the RGD- peptides and their binding properties to integrins. We present here the methodology for the synthesis of two linear RGD peptides using the Solid Phase Peptide Synthesis Method and some preliminary NMR data. RGD peptides are short peptide fragments derived from the amino acid sequence of several extracellular matrix proteins, such as fibrinogen, fibronectin, vitronectin, collagen, and laminin. The amino acid sequence Arg-Gly-Asp or RGD present on extracellular matrix proteins is known to be a requirement for binding to cell surface receptor proteins, the integrins. The binding of extracellular matrix proteins to the integrin receptors by the RGD sequence involves a number of important cellular processes, such as cell anchorage to the extracellular matrix, cell-to-cell communication, cell growth and migration, blood clotting, and so on (1, 2). Certain unnatural processes such as microbial invasion of cells and tumor metastasis are also involved with some type of ligand-to-receptor binding via the RGD sequence (3). Small RGD peptides such as the ones proposed to be synthesized in this project have been known to have the ability to bind to cell surface receptors just like the native extracellular matrix proteins do. Therefore, these little RGD peptides have been proposed to be used as antagonists to the extracellular matrix proteins (4). In this project we present the synthesis of an RGD peptide derived from the RGD region of fibrinogen, which has the sequence YNRGDST (5). Fibrinogen is a protein involved in the mechanism of blood clotting. The synthesis of this peptide was carried out manually by the Solid Phase Peptide Synthesis Method (SPPS), employing the Wang resin. The Synthesis of RGD Peptides via Solid Phase Peptide Synthesis Materials and Methods Materials and Methods Conclusions Conclusions Based on the HPLC, NMR, and mass spectral data, we conclude that the RGD peptide has been synthesized. The 2D NOESY data in the NH-NH region indicated that the peptide backbone is folded. Immediate future study is to assign all the protons on the RGD peptide molecule and further investigate its structure. O O H O bt CH O C HN HN CH CO CH 3 O CH 2 O O CH O C H 2 N CO CH 3 rem oval ofFm oc coupling of nextaa O O CH O C HN CO CH 3 HN CH O CH 2 repeatcoupling reaction w ith Asp,G ly,Arg, Asn,Tyr O O CH O C HN CO CH 3 HN CH O CH 2 HN CH 2 HN CH C CH 2 O O C NH CH 2 CH 2 HN CH CH 2 NH HN HN CH C CH 2 NH O O HN CH CH 2 H O bt = Fm oc group = Side chain protecting group H O bt = C arboxyl group activator W ang resin O O CH O C HN CO CH 3 HN CH O CH 2 HN CH 2 HN CH C CH 2 O O C NH CH 2 CH 2 HN CH CH 2 NH HN HN CH C CH 2 NH O O HN CH CH 2 rem oval ofFm oc O O CH O C HN CO CH 3 HN CH O CH 2 HN CH 2 HN CH C CH 2 O O C NH CH 2 CH 2 HN CH CH 2 NH HN HN CH C CH 2 NH O O H 2 N CH CH 2 cleavage (95% TFA) CH O C HN COH CH 3 HN CH OH CH 2 OH HN CH 2 HN CH C CH 2 OH O C NH CH 2 CH 2 HN CH CH 2 NH 2 HN HN CH C CH 2 NH 2 O OH H 2 N CH CH 2 m ixture ofR G D peptide and side chain protecting by-products EtherExtraction is done to separate the peptide (See nextdiagram ) Yellow substance in the vessel is the peptide still attached to the Wang resin. Brown substance in the vial is the Wang resin after the peptide has been cleaved from it. Figure 1. Solid Phase Peptide Synthesis M ix tu re o f R G D p e p t id e a n d s id e c h a in p ro te c t in g b y -p ro d u c ts in a q u e o u s p h a s e C a rry o u t E th e r E x tra c t io n S e p a ra t io n o f e th e r la y e r = b y -p ro d u c ts = P e p t id e C H O C H N C O H C H 3 H N C H O H C H 2 O H H N C H 2 H N C H C C H 2 O H O C N H C H 2 C H 2 H N C H C H 2 N H 2 H N H N C H C C H 2 N H 2 O O H H 2 N C H C H 2 F re e z e -d ry in g R G D p e p t id e White solid is the RGD peptide after freeze- drying has been completed. Figure 2. This figure is a HPLC chromatogram of the RGD peptide at 220 nm. A concentration of 1 mg/ml was used for analysis. The organic solvent and polar solvent used for the HPLC analysis were acetonitrile containing 0.1% TFA and water containing 0.1%TFA respectively. Figure 3. 1D 1 H-NMR spectrum of RGD peptide in DMSO; (no specific 1 H assignments have been made.) Figure 4. This figure shows the COSY 2-D 1 H-NMR spectrum. This data will be used to make all the proton assignments. Figure 5. This figure shows the 2D NOESY 1 H-NMR spectrum at the NH—NH region in DMSO, indicating that the peptide backbone is bent. References References 1. Hynes, R. O. (1992) "Integrins: Versatility, Modulation, and Signaling in Cell Adhesion," Cell. 69, 11-25. 2. Lodish, H., Baltimore, D., Arnold, B., Zipursky, L. S., Matsudaira, P., and Darnell, J. (1995) in “Molecular Cell Biology,” 3rd ed., W. H. Freeman and Co., New York, 1143-1166. 3. Cheresh, D. A., and Spiro, R. C. (1987) “Biosynthetic and Functional Properties of an Arg-Gly-Asp-directed Receptor Involved in Human Melanoma Cell Attachment to Vitronectin, Fibrinogen, and von Willebrand Factor.” J. Biol. Chem., 262, 17706-17711. 4. Greenspoon, N., Hershkoviz, R., Alon, R., Varon, D., Shenkman, B., Marx, G., Federman, S., Kapustina, G., and Lider, O. (1993) “Structural Analysis of Integrin Recognition and the Inhibition of Integrin-Meiated Cell functions by Novel Nonpeptidic Surrogates of the Arg-Gly-Asp Sequence.” Biochemistry, 32, 1001-1008. 5. Reed, J., Hull, W. E., von der Lieth, C. W., Kübler, D., Suhai, S., and Kinzel, V. (1988) “Secondary structure of the Arg-Gly-Asp recognition site in proteins involved in cell-surface adhesion. Evidence for the occurrence of nested -bends in the model hexapeptide GRGDSP.” Eur. J. Biochem., 178, 141-154. Acknowledgments : This research was supported by the UWEC University Research and Creative Activity Grant (2006 - 07) via the ORSP office. This diagram shows the chemical reactions and the steps used in the SPPS method. This illustration depicts the extraction of the RGD peptide from the by-products. [M+H] + = 812.36 amu
Transcript
Page 1: Abstract Abstract Introduction Introduction Results Chee Yang, Daniel H. Rose and Dr. Thao Yang  Chemistry  University of Wisconsin-Eau Claire Chee Yang,

AbstractAbstract

IntroductionIntroduction

ResultsResults

Chee Yang, Daniel H. Rose and Dr. Thao Yang Chee Yang, Daniel H. Rose and Dr. Thao Yang Chemistry Chemistry University of Wisconsin-Eau Claire University of Wisconsin-Eau Claire Chee Yang, Daniel H. Rose and Dr. Thao Yang Chee Yang, Daniel H. Rose and Dr. Thao Yang Chemistry Chemistry University of Wisconsin-Eau Claire University of Wisconsin-Eau Claire

The amino acid sequence Arg-Gly-Asp or RGD is present on several extracellular matrix proteins and known to be a requirement for their binding to integrins, which are a class of cell receptor proteins on cell surface. Some of the well-studied extracellular matrix proteins included fibrinogen, fibronectin, vitronectin, collagen, and laminin, which contain the RGD sequence. Subsequent studies in this project will focus on the conformational structures of the RGD-peptides and their binding properties to integrins. We present here the methodology for the synthesis of two linear RGD peptides using the Solid Phase Peptide Synthesis Method and some preliminary NMR data.

RGD peptides are short peptide fragments derived from the amino acid sequence of several extracellular matrix

proteins, such as fibrinogen, fibronectin, vitronectin, collagen, and laminin. The amino acid sequence Arg-Gly-Asp

or RGD present on extracellular matrix proteins is known to be a requirement for binding to cell surface receptor

proteins, the integrins. The binding of extracellular matrix proteins to the integrin receptors by the RGD sequence

involves a number of important cellular processes, such as cell anchorage to the extracellular matrix, cell-to-cell

communication, cell growth and migration, blood clotting, and so on (1, 2). Certain unnatural processes such as

microbial invasion of cells and tumor metastasis are also involved with some type of ligand-to-receptor binding via

the RGD sequence (3). Small RGD peptides such as the ones proposed to be synthesized in this project have

been known to have the ability to bind to cell surface receptors just like the native extracellular matrix proteins do.

Therefore, these little RGD peptides have been proposed to be used as antagonists to the extracellular matrix

proteins (4). In this project we present the synthesis of an RGD peptide derived from the RGD region of fibrinogen,

which has the sequence YNRGDST (5). Fibrinogen is a protein involved in the mechanism of blood clotting. The

synthesis of this peptide was carried out manually by the Solid Phase Peptide Synthesis Method (SPPS),

employing the Wang resin.

The Synthesis of RGD Peptides via Solid Phase Peptide Synthesis The Synthesis of RGD Peptides via Solid Phase Peptide Synthesis

Materials and MethodsMaterials and Methods

ConclusionsConclusionsBased on the HPLC, NMR, and mass spectral data, we conclude that the RGD peptide

has been synthesized.

The 2D NOESY data in the NH-NH region indicated that the peptide backbone is folded.

Immediate future study is to assign all the protons on the RGD peptide molecule and further investigate its structure.

OO

HObt

CH

O

CHN

HN CH

COCH3

OCH2

OOCH

O

CH2NCOCH3

removalof Fmoc

coupling of next aa

OOCH

O

CHNCOCH3

HN CH

OCH2

repeat couplingreaction with Asp, Gly, Arg, Asn, Tyr

OOCH

O

CHNCOCH3

HN CH

OCH2

HN CH2 HN CH

CCH2

OO

CNHCH2

CH2

HN CHCH2

NHHN

HN CH

CCH2

NHO

O

HN CHCH2

HObt

= Fmoc group

= Side chain protecting group

HObt = Carboxyl group activator

Wang resin

OOCH

O

CHNCOCH3

HN CH

OCH2

HN CH2 HN CH

CCH2

OO

CNHCH2

CH2

HN CHCH2

NHHN

HN CH

CCH2

NHO

O

HN CHCH2

removalof Fmoc

OOCH

O

CHNCOCH3

HN CH

OCH2

HN CH2 HN CH

CCH2

OO

CNHCH2

CH2

HN CHCH2

NHHN

HN CH

CCH2

NHO

O

H2N CHCH2

cleavage(95% TFA)

CH

O

CHNCOHCH3

HN CH

OHCH2

OHHN CH2 HN CH

CCH2

OHO

CNHCH2

CH2

HN CHCH2

NH2HN

HN CH

CCH2

NH2O

OH

H2N CHCH2

mixture of RGD peptide and side chain protecting by-products

Ether Extraction is doneto separate the peptide

(See next diagram)

Yellow substance in the vessel is the peptide still attached to the Wang resin. Brown

substance in the vial is the Wang resin after the peptide has been cleaved from it.

Figure 1. Solid Phase Peptide Synthesis

M i x t u r e o f R G D p e p t i d e a n d s i d e c h a i n p r o t e c t i n g b y - p r o d u c t s i n a q u e o u s p h a s e

C a r r y o u t E t h e r E x t r a c t i o n

S e p a r a t i o n o fe t h e r l a y e r

= b y - p r o d u c t s

= P e p t i d e

C H

O

CH NC O HC H 3

H N C H

O HC H 2

O HH N C H 2 H N C H

CC H 2

O HO

CN HC H 2

C H 2

H N C HC H 2

N H 2H N

H N C H

CC H 2

N H 2O

O H

H 2 N C HC H 2

F r e e z e - d r y i n g

R G D p e p t i d e

White solid is the RGD peptide after freeze-drying has been completed.

Figure 2. This figure is a HPLC chromatogram of the RGD peptide at 220 nm. A concentration of 1 mg/ml was used for analysis. The organic solvent and polar solvent used for the HPLC analysis were acetonitrile containing 0.1% TFA and water containing 0.1%TFA respectively.

Figure 3. 1D 1H-NMR spectrum of RGD peptide in DMSO; (no specific 1H assignments have been made.)

Figure 4. This figure shows the COSY 2-D 1H-NMR spectrum. This data will be used to make all the proton assignments.

Figure 5. This figure shows the 2D NOESY 1H-NMR spectrum at the NH—NH region in DMSO, indicating that the peptide backbone is bent.

ReferencesReferences1. Hynes, R. O. (1992) "Integrins: Versatility, Modulation, and Signaling in Cell Adhesion," Cell. 69, 11-25.

2. Lodish, H., Baltimore, D., Arnold, B., Zipursky, L. S., Matsudaira, P., and Darnell, J. (1995) in “Molecular Cell Biology,” 3rd ed., W. H. Freeman and Co., New York, 1143-1166. 3. Cheresh, D. A., and Spiro, R. C. (1987) “Biosynthetic and Functional Properties of an Arg-Gly-Asp-directed Receptor Involved in Human Melanoma Cell Attachment to Vitronectin, Fibrinogen, and von

Willebrand Factor.” J. Biol. Chem., 262, 17706-17711.

4. Greenspoon, N., Hershkoviz, R., Alon, R., Varon, D., Shenkman, B., Marx, G., Federman, S., Kapustina, G., and Lider, O. (1993) “Structural Analysis of Integrin Recognition and the Inhibition of Integrin-Meiated Cell functions by Novel Nonpeptidic Surrogates of the Arg-Gly-Asp Sequence.” Biochemistry, 32, 1001-1008.

5. Reed, J., Hull, W. E., von der Lieth, C. W., Kübler, D., Suhai, S., and Kinzel, V. (1988) “Secondary structure of the Arg-Gly-Asp recognition site in proteins involved in cell-surface adhesion. Evidence for the occurrence of nested -bends in the model hexapeptide GRGDSP.” Eur. J. Biochem., 178, 141-154.

Acknowledgments: This research was supported by the UWEC University Research and Creative Activity Grant (2006 - 07) via the ORSP office.

This diagram shows the chemical reactions and the steps used in the SPPS method.

This illustration depicts the extraction of the RGD peptide from the by-products.

[M+H]+ = 812.36 amu

Recommended